Panel Discussion: Overcoming Challenges for Pharmaceutical Engagement in R&D for Cannabinoid & Endocannabinoid System Targeting Drug Development
Time: 3:30 pm
day: Day One PM
Details:
- How can pharma work with other stakeholders to de-risk investment in cannabinoid drug development?
- What actions can be taken to de-stigmatise cannabinoid drug development across large pharma?
- How have the first few breakthrough regulatory approvals paved the way for more widely accepted cannabinoid drug development within pharma?
- How can emerging technologies and innovative approaches within pharma accelerate the development and commercialization of cannabinoid-based therapeutics?
